EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, RXRX: Recursion Pharmaceuticals Inc Cl A

07 Nov 25 15:59
LAST:

4.630

CHANGE:
 0.00		OPEN:
4.710		HIGH:
4.790		ASK:
0.000		VOLUME:
48.84M
CHG(%):
0.00		PREV:
4.620		LOW:
4.180		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Nov 254.5004.6404.1804.62052.64M
06 Nov 254.9804.9904.6004.62038.33M
05 Nov 255.0705.2004.8604.96057.42M
04 Nov 255.2005.3204.9705.00043.37M
03 Nov 255.5705.7605.3305.44048.32M
31 Oct 255.7005.7365.4105.52043.3M
30 Oct 255.6805.8405.6305.65033.37M
29 Oct 255.9906.1005.6805.87043.61M
28 Oct 256.2206.2505.8505.91038.64M
27 Oct 256.1506.5005.9356.30055.25M

COMPANY PROFILE

Name:Recursion Pharmaceuticals Inc Cl A
About:Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
Sector:Healthcare
Industry:Biotechnology
Address:41 South Rio Grande Street, Salt Lake City, UT, United States, 84101
Website:https://www.recursion.com
CUSIP:75629V104
CIK:0001601830
ISIN:US75629V1044
FIGI:BBG00PQ4XJ45

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-3.22 
Forward P/E:-3.19 
PEG Ratio:-1.29 
Price to Sales:37.30 
Price to Book:2.60 
Profit Margin:0.23 
Operating Margin:-9.17 
Return on Assets:-0.39 
Return on Equity:-0.86 
EPS Ratio:-1.81 
Revenue:64.6M 
Shares:429.71M 
Market Cap:1.99B 

TECHNICAL INDICATORS

MA5:4.936.4%
MA10:5.3916.4%
MA20:5.7323.8%
MA50:5.2713.8%
MA100:5.3615.7%
MA200:5.6622.3%
RSI14:17.81 
WPR14:-100.00 
MTM14:-1.49
ROC14:-0.24 
ATR:0.44 
Week High:5.7624.4%
Week Low:4.1810.8%
Month High:7.1855.1%
Month Low:4.1822.3%
Year High:12.36167.0%
Year Low:3.7922.2%
Volatility:63.21